Shimadzu Europe
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: E-News

E-News

shutterstock 1090252943

Biochemists find substance that makes cancer cells “suicidal”

, 9 November 2022/in E-News /by panglobal

The Peoples’ Friendship University of Russia (RUDN) biochemists have obtained a potential anti-cancer agent. The new substance pro-vokes cancer cells to commit “suicide” and at the same time does not affect healthy cells. The results are published in Molecules [1].

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/shutterstock_1090252943-scaled-e1680866304785.jpg 600 777 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-09 09:05:542022-11-09 09:05:54Biochemists find substance that makes cancer cells “suicidal”
Maikel Rheinstadter team

Scientists test ‘smart’ red blood cells to deliver antibiotics that target specific bacteria

, 9 November 2022/in E-News /by panglobal

Physicists at McMaster University have identified a natural delivery system which can safely carry potent antibiotics throughout the body to selectively attack and kill bacteria by using red blood cells as a vehicle.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/Maikel-Rheinstadter-team-scaled-e1680866316529.jpg 600 1013 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-09 09:01:362022-11-09 09:01:36Scientists test ‘smart’ red blood cells to deliver antibiotics that target specific bacteria
Ardigen Logo

Ardigen supports JUMP-CP Consortium scaling up image-based drug discovery with the world’s largest public Cell Painting dataset

, 9 November 2022/in E-News /by panglobal

Ardigen, one of the world’s leading artificial intelligence (AI) companies advancing precision medicine, has announced that it is supporting the Joint Undertaking in Morphological Profiling-Cell Painting (JUMP-CP) Consortium with its technology and expertise. The consortium of 10 leading pharmaceutical companies and two non-profit research organizations including the Broad Institute of MIT and Harvard, is focused […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/Ardigen-Logo.png 2516 3543 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-09 07:59:022022-11-09 07:59:02Ardigen supports JUMP-CP Consortium scaling up image-based drug discovery with the world’s largest public Cell Painting dataset
GenNext Fox

GenNext wins $250,000 Grand Prize Award at 2022 BioTools Innovator competition

, 9 November 2022/in E-News /by panglobal

GenNext Technologies, a growth-stage company that provides instrumentation, software, and services to pharmaceutical researchers, was awarded the 2022 Grand Prize Award in the BioTools Innovator competition.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/GenNext-Fox.jpg 600 450 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-09 07:56:412022-11-09 07:56:41GenNext wins $250,000 Grand Prize Award at 2022 BioTools Innovator competition
Oncodesign

Edmond de Rothschild Equity Strategies IV acquires a majority stake in Oncodesign Services

, 9 November 2022/in E-News /by panglobal

Oncodesign Services, a leading Contract Research Organization (CRO) specializing in drug discovery and preclinical services in oncology and immuno-inflammation, and Elyan Partners have completed the acquisition of a majority stake in Oncodesign Services by Edmond de Rothschild Equity Strategies IV, from its main shareholders, including Philippe Genne, founder of Oncodesign Services.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/Oncodesign.jpg 1001 1500 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-09 07:54:362022-11-09 07:54:36Edmond de Rothschild Equity Strategies IV acquires a majority stake in Oncodesign Services
Shimadzu Dr Frank Streit

Shimadzu, University Medical Center Göttingen team up to develop new clinical LC-MS methods for more rapid, flexible TDM analysis

, 9 November 2022/in E-News /by panglobal

Shimadzu is embarking on a new collaboration with the University Medical Center Göttingen (UMG) which will focus on the development of new clinical laboratory methods using liquid chromatography – mass spectrometry (LC-MS) for therapeutic drug monitoring (TDM) analysis.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/Shimadzu_Dr-Frank-Streit.jpg 662 1040 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-09 07:51:272022-11-09 07:51:27Shimadzu, University Medical Center Göttingen team up to develop new clinical LC-MS methods for more rapid, flexible TDM analysis
greiner EcoVadis

Greiner Bio-One achieves good results with sustain­ability assessment

, 9 November 2022/in E-News /by panglobal

Greiner Bio-One had its sustainability efforts evaluated for the first time for the entire Group through the EcoVadis platform and was awarded the silver medal for its commitment. The Greiner Bio-One Group achieved 60 out of 100 points. With this overall rating, the company group ranks among the top 20% of all companies evaluated. Greiner […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/greiner_EcoVadis-e1680866394410.jpg 900 1350 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-09 07:47:122022-11-09 07:47:12Greiner Bio-One achieves good results with sustain­ability assessment
sphere fluidocs granta park

Sphere Fluidics opens new lab facilities at Granta Park, UK

, 9 November 2022/in E-News /by panglobal

Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, has opened a new state-of-the-art facility in Granta Park, Cambridgeshire, UK, to support the company’s growth. Doubling overall capacity, the laboratories enable the team’s accelerated expansion, and the development of new, innovative products.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/sphere_fluidocs_granta_park.png 1128 1778 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-09 07:44:242022-11-09 07:44:24Sphere Fluidics opens new lab facilities at Granta Park, UK
shutterstock 1924512605

Navigo, Mannin agree to develop affinity ligand against a novel drug for treatment of COVID-19

, 8 November 2022/in E-News /by panglobal

Navigo Proteins, a premier protein engineering company and developer of affinity ligands for custom chromatography solutions and Mannin, a subsidiary of Mannin Research Inc. (MRI), have agreed to develop a Precision X affinity ligand against the fusion protein of Angiopoietin-1 and Complement 4 Binding Protein (ANG1-C4BP) for use in GMP manu­facturing. Mannin, and its parent […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/shutterstock_1924512605-scaled-e1680866408731.jpg 900 1600 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-08 19:33:552022-11-08 19:33:55Navigo, Mannin agree to develop affinity ligand against a novel drug for treatment of COVID-19
ZiathEpromo2022J image

Ziath issues guide for common 2D barcode scanning problems and how to prevent them

, 8 November 2022/in E-News /by panglobal

2D barcoded tubes are a de facto standard for high integrity sample management. However, while 2D barcoded tubes offer excellent performance, to get the most from them requires a good knowledge of common 2D barcode scanning problems and how to prevent them. A 20-page guide from Ziath provides informative solutions to the most encountered scanning […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/ZiathEpromo2022J-image.jpg 642 456 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-08 19:28:402022-11-08 19:28:40Ziath issues guide for common 2D barcode scanning problems and how to prevent them
Page 48 of 228«‹4647484950›»
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

November 2025

CLi Cover nov 2025
15 December 2025

WERFEN APPLAUDS SIGNIFICANT PUBLICATION URGING ACTION ON THE RISKS OF UNDETECTED HEMOLYSIS

13 December 2025

Indero validates three-day gene expression method

12 December 2025

Johnson & Johnson acquires Halda Therapeutics for $3.05 billion

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription